OBX — Obsidian Therapeutics Share News
0.000.00%
Last trade - 00:00- $861.11m
- $861.11m
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM
NASDAQ RESUMED AT 10:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:33 AM
NASDAQ RESUMED AT 11:19 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:09 AM
Brief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement
Brief: Galera Therapeutics Receives Letter From Nasdaq Indicating That Co Has Not Regained Compliance With Listing Rules
Brief: Yair Schneid Reports 13.073% Passive Stake In Galera Therapeutics - SEC Filing
Brief: Galera Announces Receipt Of Type A Meeting Minutes And Strategic Update
Brief: Galera Therapeutics Inc - Received Notices Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Galera Schedules Type A Meeting With FDA To Discuss Next Steps For Inflammation Disease Drug
Galera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary